Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to develop and evaluate a blood test for asymptomatic heavy smokers to screen for those at highest risk of developing lung cancer. The aim of this study is to d...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Everest Detection, Inc.
NCT02688894 · Small Cell Lung Cancers, Neuroendocrine Carcinoma
NCT06810375 · Lung Cancers
NCT05857995 · Lung Cancer, Pulmonary Neoplasm, and more
NCT07057648 · Lung Nodules, Peripheral Lung Lesions, and more
NCT07064395 · Lung Cancers
Site 101
Oklahoma City, Oklahoma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions